Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.9900
0.033.13%
Last update: Dec 15, 8:13 AM
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy RenovoRx (RNXT) stock?
You can purchase shares of RenovoRx (NASDAQ:RNXT) through any online brokerage.
Who are RenovoRx (RNXT) competitors?
Other companies in RenovoRx’s space includes: Serina Therapeutics Inc (AMEX:SER), Skye Bioscience Inc (NASDAQ:SKYE), FibroGen Inc (NASDAQ:FGEN), Cue Biopharma Inc (NASDAQ:CUE) and XOMA Royalty Corp (NASDAQ:XOMAO).
What is the forecast, or price target, for RenovoRx (RNXT) stock?
RenovoRx has a consensus price target of $8.13.
What is the current price for RenovoRx (RNXT)?
The stock price for RenovoRx (NASDAQ: RNXT) is $0.99 last updated December 15, 2025 at 8:13 AM EST.
Does RenovoRx (RNXT) pay a dividend?
There are no upcoming dividends for RenovoRx.
When is RenovoRx (NASDAQ:RNXT) reporting earnings?
RenovoRx does not have any upcoming earnings scheduled.
Is RenovoRx (RNXT) going to split?
There is no upcoming split for RenovoRx.
What sector and industry does RenovoRx (RNXT) operate in?
RenovoRx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
